Tóth K - Search Results

1

Szapáry L, Késmárky G, Tóth K, Misnyovszky M, Tóth T, Balogh A, Nagy K, Németh GY, Fehér G. Szapáry L, et al. Among authors: toth t, toth k. Ideggyogy Sz. 2012 Nov 30;65(11-12):387-93. Ideggyogy Sz. 2012. PMID: 23289173 Review. Hungarian.

2

[Hemorheologic parameters in coronary artery disease].

Késmárky G, Tóth K, Habon L, Vajda G, Juricskay I. Késmárky G, et al. Among authors: toth k. Orv Hetil. 1998 Jun 14;139(24):1465-8. Orv Hetil. 1998. PMID: 9658864 Clinical Trial. Hungarian.

3

Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.

Toth K, Kesmarky G, Vekasi J, Nemes J, Czopf L, Kapronczay P, Halmosi R, Papp E, Juricskay I. Toth K, et al. Clin Hemorheol Microcirc. 1999;21(3-4):209-16. Clin Hemorheol Microcirc. 1999. PMID: 10711745

4

Omega-3 fatty acids improve haemodynamic and haemorheologic parameters and lipid profiles in patients with cardiovascular diseases.

Habon T, Kesmarky G, Toth K. Habon T, et al. Among authors: toth k. Eur Heart J. 2002 Jan;23(1):89. doi: 10.1053/euhj.2001.2794. Eur Heart J. 2002. PMID: 11741369 No abstract available.

5

[Scavenger effect of various cerebrovascular drugs].

Horváth B, Márton Z, Halmosi R, Alexy T, Szapáry L, Vékási J, Bíró Z, Habon T, Késmárky G, Tóth K. Horváth B, et al. Among authors: toth k. Orv Hetil. 2002 Jan 6;143(1):13-7. Orv Hetil. 2002. PMID: 11816373 Hungarian.

6

In vitro antioxidant properties of pentoxifylline, piracetam, and vinpocetine.

Horvath B, Marton Z, Halmosi R, Alexy T, Szapary L, Vekasi J, Biro Z, Habon T, Kesmarky G, Toth K. Horvath B, et al. Among authors: toth k. Clin Neuropharmacol. 2002 Jan-Feb;25(1):37-42. doi: 10.1097/00002826-200201000-00007. Clin Neuropharmacol. 2002. PMID: 11852295

7

[The effect of carvedilol on enhanced adp-ribosylation and red blood cell membrane damage caused by free radicals].

Habon T, Szabados E, Késmárky G, Halmosi R, Past T, Sumegi B, Tóth K. Habon T, et al. Among authors: toth k. Acta Pharm Hung. 2001 Oct;71(3):306-13. Acta Pharm Hung. 2001. PMID: 11961898 Hungarian.

8

[Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].

Szapáry L, Horváth B, Alexy T, Márton Z, Késmárky G, Szóts M, Nagy F, Czopf J, Tóth K. Szapáry L, et al. Among authors: toth k. Orv Hetil. 2003 May 18;144(20):973-8. Orv Hetil. 2003. PMID: 12830727 Clinical Trial. Hungarian.

9

[Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].

Szapáry L, Szóts M, Horváth B, Márton Z, Alexy T, Késmárky G, Juricskay I, Nagy F, Gaál V, Pálfi A, Koltai K, Tóth K. Szapáry L, et al. Among authors: toth k. Orv Hetil. 2003 Jun 1;144(22):1085-90. Orv Hetil. 2003. PMID: 12847818 Hungarian.

10

Short-term effects of atorvastatin on haemorheologic parameters, platelet aggregation and endothelium dysfunction in patients with hypercholesterolaemia.

Horvath B, Marton Z, Alexy T, Kesmarky G, Toth K, Szapary L. Horvath B, et al. Among authors: toth k. Eur Heart J. 2004 Jan;25(1):96. doi: 10.1016/j.ehj.2003.05.002. Eur Heart J. 2004. PMID: 14683748 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,161 results

Search Page